Noelle V. Frey

2 ta ish

University of Pennsylvania

1. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

   Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando +34

   MaqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.020493

2. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

   Melody Smith, Anqi Dai, Guido Ghilardi +46

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480531